ライフサイエンスコーパス: virally

1 hereas knockdown of AIP by siRNA potentiates virally activated IFN production.

2 ntral to the efficient immune recognition of virally and malignantly transformed cells.

3 munotherapy has clinical activity in certain virally associated cancers.

4 geting nonviral antigens in immunotherapy of virally associated cancers.

5 ers' diarrhea and in tear fluid derived from virally associated corneal disease.

6 ults argued that the antitumor efficacy of a virally based transgene therapeutic relied strongly on a

7 Virally based transsynaptic tracing technologies are pow

8 as it is both physiologically protective and virally conducive.

9 recapitulates the neuroinflammatory state of virally controlled individuals and the associated struct

10 amate release ex vivo in BNST from mice with virally delivered channelrhodopsin2 (ChR2) expression in

11 Here, we used virally delivered fluorescent probes and in vivo time-la

12 of these lamina terminalis AT1aR neurons, we virally delivered light-sensitive opsins and then optoge

13 ed to enter trials in the next 1-2 years and virally delivered RNA interference and zinc finger trans

14 Virally delivered short interfering RNA (siRNA) ensured

15 Gene silencing with virally delivered shRNA represents a promising approach

16 -CRISPR-associated protein 9 (Cas9) with non-virally delivered template DNA for the elimination of en

17 ype I interferons (IFN-I) in the efficacy of virally delivered therapeutic genes.

18 containing genes are minimally affected, and virally delivered ZFP-TFs are active and well tolerated

19 fic knockout of CB1 or MAGL via injection of virally-delivered Cre recombinase into the MSDB of Cnr1(

20 hybrid gene delivery agents comprising both virally derived and synthetic materials (nanobiovectors)

21 cell lines used in ICD studies often express virally derived peptides that are recognized by the immu

22 We hypothesize that a virally-derived SBF may have initially hijacked cell cyc

23 ular release mechanisms in NTS astrocytes by virally driven expression of a dominant-negative SNARE p

24 nsive map for future experiments that employ virally driven neuromodulation techniques to predict ana

25 Key to this destruction is the virally encoded alkaline exonuclease SOX.

26 helix" that is structurally homologous to a virally encoded anti-CRISPR protein (AcrIF3).

27 fter dsDNA binding, or in complex with three virally encoded anti-CRISPR suppressors that inhibit dsD

28 We previously showed that the virally encoded BPLF1 protein interacts with and regulat

29 porting the notion that ICP22 functions as a virally encoded cochaperone (J-protein/Hsp40) functionin

30 abundant tegument protein, as being the only virally encoded component responsible for these cytoskel

31 be common features of DNA transport through virally encoded conduits.

32 nts the first high-resolution structure of a virally encoded DNA-translocating conduit.

33 ed ribonuclease H (RNase H) remains the only virally encoded enzymatic function not targeted by curre

34 ed ribonuclease H (RNase H) remains the only virally encoded enzymatic function yet to be exploited a

35 This reaction is catalysed by the virally encoded enzyme integrase (IN) and is facilitated

36 The glycans on fibrils are produced by virally encoded enzymes, organized in gene clusters.

37 virus genome is packaged with protein VII, a virally encoded histone-like core protein that is sugges

38 ontext of virus infection that NSs acts as a virally encoded IFN antagonist and that NSs is dispensab

39 V disease pathology is the interplay between virally encoded immune antagonists and host components t

40 MCV lesions persist because of virally encoded immune evasion molecules that inhibit an

41 the viral lifecycle that is catalyzed by the virally encoded IN protein within a nucleoprotein assemb

42 ot prematurely terminated, expression of the virally encoded lytic switch protein needs to be sustain

43 strains are proteolytically processed by the virally encoded main protease.

44 easurements demonstrate that expression of a virally encoded melanopsin lacking all C-terminal phosph

45 Here we show that the virally encoded miR-K10a miRNA, whose precursor overlaps

46 Since the identification of virally encoded miRNAs, various mRNAs have been identifi

47 unction with nsp10, methylates the 5'-end of virally encoded mRNAs to mimic cellular mRNAs, thus prot

48 sed on reversion to fluorescence in a set of virally encoded mutant green fluorescent proteins, which

49 ll response to infection in the absence of a virally encoded NF-kappaB inhibitor, U(L)26.

50 A) genome of the virus is wrapped around the virally encoded nucleoprotein N to form the ribonucleopr

51 ISVP* formation releases two virally encoded peptides, myristoylated mu1N (myr-mu1N)

52 ect the T cells and remain latent due to the virally encoded product Tax inhibiting a key host defens

53 this proteolytic cleavage is mediated by the virally encoded protease AVP.

54 enes involved in latency, UL133-UL138, and a virally encoded protein kinase, UL97, which plays crucia

55 scriptionally controlled by a complex of six virally encoded proteins that hijack the host transcript

56 in the nucleus prior to genome packaging by virally encoded Rep proteins.

57 ZIKV replicates its RNA genome using virally encoded replication proteins.

58 Positive strand RNA viruses replicate via a virally encoded RNA-dependent RNA polymerase (RdRP) that

59 re successfully incorporated into RNA by the virally encoded RNA-dependent RNA polymerase (RdRp).

60 These viruses replicate by using a virally encoded RNA-dependent RNA polymerase enzyme that

61 The virally encoded site-specific recombinase Int collaborat

62 ng varicella and herpes zoster, expresses 24 virally encoded sncRNA (VZVsncRNA) in infected cells.

63 hat VZV replication is modulated by multiple virally encoded sncRNA, revealing an additional layer of

64 This study represents the first report of a virally encoded sugar acetyltransferase.

65 Utilizing expression of a virally encoded synaptic anterograde tracer, AAV-Synapto

66 The virally encoded Tat protein hijacks positive transcripti

67 - and gammaherpesviruses depends on a set of virally encoded transcriptional activators (vTAs) that h

68 HIV-1 counteracts restriction with the virally encoded Vif protein, which forms a hybrid ubiqui

69 ght/dark cycle compared with mice expressing virally encoded WT melanopsin; however, the phase angle

70 The retroviral integrases are virally encoded, specialized recombinases that catalyze

71 mode of DRAM, established rules to identify virally-encoded auxiliary metabolic genes (AMGs), result

72 ecifically, we developed beta-cell-selective virally-encoded fluorescent protein biosensors that can

73 Virally-encoded glycosphingolipids (vGSLs) are virulence

74 ellular antiviral response involving vMIA, a virally-encoded protein that is not only able to prevent

75 es in the infected host thanks to dedicated, virally-encoded RNA-dependent RNA polymerases (RdRps).

76 fined murine models of atopic, nonatopic and virally exacerbated forms of pulmonary inflammation, we

77 We virally expressed an excitatory designer receptor exclus

78 s established the expression and function of virally expressed Channelrhodopsin (ChR2) in CST cell bo

79 Virally expressed FMRP restored WT HCN channel-related d

80 en these phosphorylation-deficient MORs were virally expressed in MOR knockout rats.

81 We virally expressed inhibitory hM4Di DREADD (designer rece

82 Activation of virally expressed KORD in several neuronal contexts robu

83 tion to ncRNAs, diverse biological roles for virally expressed ncRNAs have been described, including

84 he glycoproteins of filoviruses are the only virally expressed proteins on the virion surface and are

85 of mutant ataxin-1 (ATXN1) expression, using virally expressed RNAi triggers, could prevent disease s

86 To address this hypothesis, we virally expressed the genetically encoded calcium sensor

87 When virally expressed to projection neurons in vivo, mGreenL

88 large premotor CbN cells over development by virally expressing channelrhodopsin in the inferior oliv

89 By virally expressing the isoforms in dopamine neurons of D

90 When expressed virally in "indirect pathway" medium spiny neurons (iMSN

91 Virally increasing Crem levels decreased impulsive actio

92 Castleman disease (MCD), a life-threatening, virally induced B-cell lymphoproliferative disorder.

93 However, the molecular mechanisms leading to virally induced cancer development have yet to be fully

94 s crucial to understanding the mechanisms of virally induced disease.

95 bility or resistance to viral infections and virally induced diseases have often been first identifie

96 Unlike genetic alterations, these virally induced epigenetic changes can be reversed pharm

97 ronic systemic inflammation that intensifies virally induced hyperinflammation associated with SARS-C

98 at ACLY is not essential for HCMV growth and virally induced lipogenesis.

99 The virally induced mechanism counteracted defects in the pr

100 However, it is clear that virally induced metabolic reprogramming can substantiall

101 acer for activated T cells in vitro and in a virally induced model of rhabdomyosarcoma.

102 This work characterizes a virally induced modulation of the innate immune response

103 useful for developing novel mouse models of virally induced neurological diseases with heterogenous

104 Repair of virally induced oxidative damage by the DNA MMR pathway

105 ated that this immunization strategy against virally induced pneumococcal disease can be conferred wi

106 s through exposure to tobacco and alcohol or virally induced tumorigenesis.

107 We have shown that virally induced upregulation of cellular Mcl-1 promotes

108 ells exhibit E1B 19K-dependent repression of virally induced, NF-kappaB-dependent macrophage cytokine

109 Here, we propose that interactions of virally-induced ACE2 deficiency with obesity and/or diab

110 s are innate-like lymphocytes that eliminate virally infected and cancerous cells, but the mechanisms

111 fective serial killers capable of destroying virally infected and cancerous targets by polarized rele

112 ) use polarized secretion to rapidly destroy virally infected and tumor cells.

113 te immune system that are capable of killing virally infected and/or cancerous cells.

114 to explain the full extent of the disease in virally infected animals.

115 ve microglial activation and astrogliosis in virally infected brains.

116 an individual, understanding the dynamics of virally infected CD4(+) TSCM during suppressive ART is i

117 e immune signaling, eliciting effects within virally infected cells and after release from dying cell

118 lls protect from viral infections by killing virally infected cells and secreting interferon-gamma.

119 that T cell functions important for clearing virally infected cells are impaired by higher negative r

120 e immune inflammation during accumulation of virally infected cells at sites of infection and suggest

121 host immune molecules that kill bacteria and virally infected cells by pore formation, and mutations

122 arely, arising from one or a small subset of virally infected cells infrequently evolving into a path

123 Effective clearance of virally infected cells requires the sequential activity

124 ght induce greater inflammatory responses to virally infected cells than E1B 19K-positive vectors, be

125 into the host genome creates a reservoir of virally infected cells that persists throughout life, ne

126 (+) cytotoxic T lymphocytes (CTLs) eliminate virally infected cells through directed secretion of spe

127 NK cells provide a defense against virally infected cells using a variety of cytotoxic mech

128 -derived peptides previously identified from virally infected cells via mass spectrometry.

129 ed to induce apoptosis of tumor cells and/or virally infected cells, although sparing normal cells, a

130 to their direct cytotoxicity toward tumors, virally infected cells, and stressed cells, and they als

131 ld be a potential antiviral strategy against virally infected cells, particularly those harboring a l

132 While interferons help kill virally infected cells, they can also promote systemic i

133 ptosis functions as a trap door to eliminate virally infected cells.

134 cular cellular needs or blocked in cancer or virally infected cells.

135 d worked cooperatively in the elimination of virally infected cells.

136 idered to cause apoptosis in tumor cells and virally infected cells.

137 V-1 replication but does not fully eliminate virally infected cells.

138 tic, immunorepressive cell death activity of virally infected cells.

139 Immune cell entry into the virally infected CNS is vital for promoting viral cleara

140 activity depended upon direct contact of the virally infected corpses with responder macrophages.

141 ation of toll-like receptor (TLR) ligands to virally infected germfree mice limits neurologic damage.

142 relevance for redirecting T cells to target virally infected hepatoma cells.IMPORTANCE Due to the pr

143 imilarly, the CXCR4 antagonist released from virally infected human CAOV2 ovarian carcinoma cells inh

144 is the first ex vivo demonstration that non-virally infected human T cells can express NKG2DL, with

145 y driving immune response in the hepatitis B virally infected liver cancer TCGA cohort, and uncovered

146 ed previously published reports by detecting virally infected memory and naive B cells, but also iden

147 used to redirect naive T cells to eliminate virally infected or cancerous cells; however, they are p

148 n immediate and direct cytolytic response to virally infected or malignantly transformed cells.

149 Cytotoxic lymphocytes eliminate virally infected or neoplastic cells through the action

150 rapidly produce effector cytokines and kill virally infected or transformed cells, NK cells also exh

151 e innate lymphocytes that recognize and lyse virally infected or transformed cells.

152 lly spreads within this cell population when virally infected T cells dock to uninfected target T cel

153 in promoting survival and transformation of virally infected T cells.

154 estricted cytotoxicity toward transformed or virally infected target cells.

155 Natural killer (NK) cells kill virally infected/transformed cells via degranulation of

156 lymphocytes to mount responses to cancer and virally-infected cells, dendritic cells must capture ant

157 The rapid identification of virally-infected crops allowing containment is essential

158 icrobial metabolism and epithelial repair in virally inflamed gut and as a potential mitochondrial ta

159 The complicated etiologies of these virally influenced diseases are difficult to study in co

160 We validate optical actuation by virally introducing optogenetic drivers in rat and human

161 responses in white matter stroke, OPCs were virally labeled and laser-captured in the region of part

162 Conversely, virally mediated activation of NF-kappaB signaling decre

163 These data reveal that virally mediated ectopic expression of human rod opsin c

164 In 8- to 10-week-old A2A-Cre mice, we used virally mediated Egr3 overexpression in NAc D2-MSNs to t

165 Virally mediated expression of Channelrhodopsin in ventr

166 Virally mediated expression of GIRK3 in the ventral tegm

167 Here we use virally mediated GABAergic-specific GCaMP6f expression t

168 Thus our findings indicate that virally mediated HDAC inhibition can act as a signal for

169 gh central pharmacological administration or virally mediated hypothalamic overexpression converts th

170 hat nitric oxide protects beta-cells against virally mediated lysis by limiting EMCV replication.

171 Here, we asked whether virally mediated neurotrophin3 (NT3) overexpression can

172 We used virally mediated RNA interference to locally downregulat

173 g Cre recombinase-dependent adeno-associated virally mediated transfection.

174 Virally-mediated over-expression of S1PR3 in the mPFC pr

175 Here, we investigate how virally-mediated overexpression of alpha-synuclein in th

176 ulting apoptotic bodies (ApoBods) containing virally modified dsDNA could induce autoimmunity in an a

177 d proof of principle in an animal model that virally modified dsDNA in apoptotic bodies could break t

178 me pathways are hijacked by viruses and that virally modified exosomes contribute to virus spread and

179 to trigger adaptive immune responses against virally or malignantly transformed cells.

180 AP uses an anti-GFP ribosomal tag (expressed virally or using transgenesis) to immunoprecipitate tran

181 To test this hypothesis, we virally overexpressed CREB in CA1 of dorsal hippocampus.

182 We virally overexpressed D2Rs on nucleus accumbens core (D2

183 ing potassium (GIRK2; Kir 3.2) channels were virally overexpressed in the striatum, and the resulting

184 Given that SGK1 mutants virally overexpressed in the VTA are capable of altering

185 -receptor synaptic activity was assessed via virally overexpressed potassium channels (GIRK2) in medi

186 gs from CHIs and medium spiny neurons (MSNs) virally overexpressing G-protein-activated inwardly rect

187 C phosphorylation during early withdrawal by virally overexpressing SRCIN1, a negative regulator of S

188 neutralizing antibodies that recognize these virally presented glycans.

189 s can be developed to selectively target the virally reconfigured host cell networks that accompany a

190 RT; and (4) proportion of stage 3 who became virally suppressed (</=200 copies/mL).

191 ipants (31%) were food insecure and 79% were virally suppressed (<20 copies/mL).

192 l {CI}, 3.21-3.87]) but still elevated among virally suppressed (<400 copies/mL) persons (adjusted RR

193 en and 60 (46%) of 131 HIV-positive men were virally suppressed (<50 copies per mL).

194 be prescribed ART (52% vs 94%; P < .01) and virally suppressed (39% vs 77%; P < .01) than uninsured

195 ositive (83%, 65%, 34%, and 50%), fewer were virally suppressed (53%, 48%, 61%, and 67%), and more ha

196 respectively), and participants who were not virally suppressed (6.3 vs 4.7 per 1000 person-years for

197 tage were 84% diagnosed, 84% on ART, and 85% virally suppressed (60% of people living with HIV).

198 (proportion of days covered [PDC] >=90%) and virally suppressed (HIV RNA <200 copies/mL), before and

199 Participants were virally suppressed (HIV-1 RNA <50 copies per mL) on efav

200 Participants were virally suppressed (HIV-1 RNA <50 copies per mL) on rilp

201 5% and 12% less likely, respectively, to be virally suppressed (P </= .02) than those with RWHAP onl

202 ve partner, and the HIV-positive partner was virally suppressed (plasma HIV-1 RNA <200 copies per mL)

203 s with viral load measurements (n=3066) were virally suppressed (translating to 106,371 individuals o

204 Among HIV+ men, 95% were virally suppressed (viral load <400 copies/mL).

205 ge of person-time spent in care, on ART, and virally suppressed among 19 521 women (21.4%), men who h

206 At baseline, 67% of participants were virally suppressed and 35% reported food insecurity.

207 At baseline, 59% of participants were virally suppressed and 45% reported food insecurity.

208 he general population, even in those who are virally suppressed and have high CD4 counts.

209 patients (64%) initiated treatment and were virally suppressed at 10 mo, compared to 96/190 (51%) in

210 re 85.2% more likely to be both retained and virally suppressed at 12 months (95% CI: 35.9, 100.0).

211 roup and 156 (82%) in the control group were virally suppressed at 24 weeks (odds ratio 1.14, 95% CI

212 itiated ART, and of those more than 80% were virally suppressed at 9 months.

213 e included data from PLWH not on ART and not virally suppressed at enrollment.

214 udy was conducted in PBMC of 20 HIV-infected virally suppressed children on ART (mean age 9.4 y), cla

215 D163 was associated with plaque formation in virally suppressed HIV+ men (RR 1.52, 95% CI 1.04-2.22);

216 Peripheral blood was collected from 70 virally suppressed HIV-1-infected individuals from Rakai

217 both cell line models and CD4+ T cells from virally suppressed HIV-1-infected individuals.

218 (LRAs) in ex vivo CD4(+) memory T cells from virally suppressed HIV-infected individuals and in an in

219 ture of primary CD4(+) T cells isolated from virally suppressed HIV-infected individuals enable obtai

220 ved from memory CD4(+) T cells isolated from virally suppressed HIV-infected individuals that recapit

221 ribute to progressive neurological damage in virally suppressed HIV-infected individuals.

222 -term clinical and immunological outcomes of virally suppressed HIV-positive individuals.

223 Furthermore, virally suppressed individuals experience chronic immune

224 s of latency reversal in CD4(+) T cells from virally suppressed individuals, we identify the T(EM) su

225 (LN; n = 9), and rectal tissue (n = 17) from virally suppressed individuals.

226 eported persistent infection of monocytes in virally suppressed individuals; however, others failed t

227 sistence of latently HIV-1 infected cells in virally suppressed infected patients, a number of in vit

228 participants not living with HIV and in PLWH virally suppressed on 1 of 3 cART regimens.

229 lubs, where groups of 25-30 patients who are virally suppressed on antiretroviral therapy (ART) meet

230 a longitudinal observational trial; all were virally suppressed on ART at year 1 and thereafter.

231 Overall prevalence of DSPN among those virally suppressed on cART decreased: 20.3%, week 48; 15

232 gative chronic hepatitis, treatment-naive or virally suppressed on nucleos(t)ide analogues.

233 h HIV (PLHIV) who are diagnosed, on ART, and virally suppressed out of the estimated number of PLHIV.

234 TW and CW had similar proportions virally suppressed over time (TW, 36% in 2001 and 80% in

235 Virally suppressed participants receiving antiretroviral

236 useful as independent prognostic markers in virally suppressed patients on ART.

237 scription (Tat) continues to be expressed in virally suppressed patients on cART.

238 time from initiation of cART to start of the virally suppressed period were risk factors for not achi

239 entry were assessed using the chi2 test, and virally suppressed PLWH were assessed using generalized

240 In virally suppressed subjects, the approach identified lat

241 deficiency virus (HIV) are less likely to be virally suppressed than cisgender women (CW) and cisgend

242 ce were more likely to be prescribed ART and virally suppressed than those with other types of health

243 AP were more likely to be prescribed ART and virally suppressed than those without RWHAP supplementat

244 ths (IQR, 1.5 to 6.5) after EDI and remained virally suppressed thereafter.

245 Virally suppressed Ugandans had a 3-fold lower frequency

246 as 48%, and the proportion of PLHIV who were virally suppressed was 40%.

247 The cost per person virally suppressed was a co-primary outcome of the study

248 Findings did not differ by HIV control (virally suppressed with CD4 counts >=500 cells/mm3 or no

249 rehensive care for >6 months (whether or not virally suppressed) is <13:100 000.

250 ms for 72% (90% diagnosed times 80% of those virally suppressed) viral suppression among persons with

251 sgender women (79.8% retained in care, 79.0% virally suppressed), 143,173 cisgender women (83.7% reta

252 sgender women (83.7% retained in care, 84.0% virally suppressed), and 382,591 cisgender men (81.0% re

253 cisgender men (81.0% retained in care, 85.9% virally suppressed).

254 (88% of 1321 with available viral load) were virally suppressed, and 673 HIV-negative men (40% of 167

255 inflammatory biomarkers among PLHIV who were virally suppressed, and this was independent of traditio

256 ential marker of the latent HIV reservoir in virally suppressed, perinatally HIV-infected adolescents

257 rvoir resides mainly in CD32-CD4+ T cells in virally suppressed, perinatally HIV-infected adolescents

258 artum; with 39% and 31% retained in care and virally suppressed, respectively, at 1 year postpartum,

259 partum, and 25% and 34% retained in care and virally suppressed, respectively, at 2 years postpartum.

260 22.5%) less person-time in care, on ART, and virally suppressed, respectively, than Hispanics.

261 CI, 3.8%-19.3%) less person-time on ART and virally suppressed, respectively, than whites.

262 hieved the UNAIDS target of 73% of all PLHIV virally suppressed, significant progress since 2013 when

263 At baseline, 300 participants (77%) were virally suppressed.

264 t (ART), and 90% of those taking ART will be virally suppressed.

265 erall, 91% were prescribed ART, and 75% were virally suppressed.

266 escribed antiretroviral therapy and 62% were virally suppressed.

267 ars (interquartile range, 4-10) and 96% were virally suppressed.

268 ART), and that 90% of those on treatment are virally suppressed.

269 those ever on ART, or 73% of all PLHIV, were virally suppressed.

270 ing men who are less likely than women to be virally suppressed.

271 ogress since 2013 when 60% of all PLHIV were virally suppressed.

272 ransmission from HIV-positive people who are virally suppressed; however, coverage of these intervent

273 ecific memory B cells in peripheral blood of virally-suppressed HIV-infected individuals and healthy

274 In a cross-sectional study, including 95 virally-suppressed seropositive and 84 demographically-m

275 couples with the HIV-positive partner taking virally suppressive antiretroviral therapy (ART) is limi

276 s to disease morbidity and can occur despite virally suppressive antiretroviral therapy (ART).

277 activity with an HIV-positive partner taking virally suppressive ART.

278 among persons with HIV-1 infection receiving virally suppressive therapy.

279 nfer IFN-mediated anti-Fv3 protection to the virally susceptible X. laevis kidney (A6) cell line.

280 ostriatal terminals when ChR2 expression was virally targeted to the intralaminar thalamus.

281 cuit integration in the adult brain, we have virally traced local corticotropin-releasing hormone (CR

282 hanism for microglia-mediated elimination of virally transduced cells in the central nervous system.

283 on with IL-4 or IL-13, HR(-) ETPs expressing virally transduced HR also exhibit STAT6 phosphorylation

284 We have characterized the usage of virally transduced or transgenically expressed extracell

285 ic imaging, we demonstrate rapid kinetics of virally transduced or transgenically expressed glutamate

286 Htr3a-Cre mice were then virally transduced to express halorhodopsin to allow act

287 oferlin (Otof (-/-) mice of both sexes) were virally transduced with cDNAs of various mini-otoferlins

288 l cells, known to be enriched for PCFUs, and virally transduced with shRNAs to knock down GLIS3 and o

289 iously shown that plasmid polyplexes can non-virally transfect SVZ NPCs when directly injected in the

290 in the same preparation were obtained using virally transfected fluorescent labeling or by immunolab

291 axons independent of transmitter status, we virally transfected VTA neurons with channelrhodopsin-2

292 ng being adenomas or adenocarcinomas [4, 5], virally transformed fish cells [6-8], or products of coa

293 ifferent clinical presentations of viral and virally triggered ("paraviral") exanthems is necessary f

294 d exaggerated cell death in animal models of virally triggered IBD and allogeneic hematopoietic stem

295 RIPK1 inhibition ameliorated disease in the virally triggered IBD model.

296 3.346, 13.848) were at higher risk of being virally unsuppressed within the hotspots.

297 2.907, 25.398) were at higher risk of being virally unsuppressed within the hotspots.

298 l and systemic routes of administration of a virally vectored vaccine.

299 Virally vectored vaccines that spread autonomously throu

300 We conclude that vaccination with virally-vectored Pd antigens induced antifungal immunity